Biotechnology pharmaceutical product discovery and development company.
H.R. 2810, S: Medicare Patient Access and Quality Improvement Act of 2013.

Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program. H.R. 523: Protect Medical Innovation Act of 2013.
MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX